Cortex Pharmaceutic Stock Cash Flow From Operations
| PHXDelisted Stock | USD 4.35 0.00 0.00% |
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess CORTEX PHARMACEUTIC's long-term financial health and intrinsic value.
CORTEX |
CORTEX PHARMACEUTIC Company Cash Flow From Operations Analysis
CORTEX PHARMACEUTIC's Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.
Current CORTEX PHARMACEUTIC Cash Flow From Operations | 18.08 M |
Most of CORTEX PHARMACEUTIC's fundamental indicators, such as Cash Flow From Operations, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, CORTEX PHARMACEUTIC is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Operating Cash Flow shows the difference between reported income and actual cash flows of the company. If a firm does not have enough cash or cash equivalents to cover its current liabilities, then both investors and management should be concerned about the company having enough liquid resources to meet current and long term debt obligations.
CompetitionIn accordance with the recently published financial statements, CORTEX PHARMACEUTIC has 18.08 M in Cash Flow From Operations. This is 99.48% lower than that of the Oil, Gas & Consumable Fuels sector and 93.58% lower than that of the Energy industry. The cash flow from operations for all Germany stocks is 98.14% higher than that of the company.
CORTEX Cash Flow From Operations Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses CORTEX PHARMACEUTIC's direct or indirect competition against its Cash Flow From Operations to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of CORTEX PHARMACEUTIC could also be used in its relative valuation, which is a method of valuing CORTEX PHARMACEUTIC by comparing valuation metrics of similar companies.CORTEX PHARMACEUTIC is currently under evaluation in cash flow from operations category among its peers.
CORTEX Fundamentals
| Return On Equity | 0.0555 | |||
| Return On Asset | 0.0185 | |||
| Profit Margin | 0.19 % | |||
| Operating Margin | (0.04) % | |||
| Current Valuation | 182.81 M | |||
| Shares Outstanding | 37.92 M | |||
| Shares Owned By Insiders | 15.10 % | |||
| Shares Owned By Institutions | 69.39 % | |||
| Number Of Shares Shorted | 123.3 K | |||
| Price To Earning | 21.21 X | |||
| Price To Book | 1.31 X | |||
| Price To Sales | 4.58 X | |||
| Revenue | 34.27 M | |||
| Gross Profit | 30.11 M | |||
| EBITDA | 15.32 M | |||
| Net Income | 2.32 M | |||
| Cash And Equivalents | 3.4 M | |||
| Cash Per Share | 0.12 X | |||
| Total Debt | 30.2 M | |||
| Debt To Equity | 0.30 % | |||
| Current Ratio | 1.49 X | |||
| Book Value Per Share | 3.44 X | |||
| Cash Flow From Operations | 18.08 M | |||
| Short Ratio | 0.13 X | |||
| Earnings Per Share | 0.19 X | |||
| Target Price | 4.35 | |||
| Number Of Employees | 18 | |||
| Beta | 0.064 | |||
| Market Capitalization | 164.96 M | |||
| Total Asset | 163.92 M | |||
| Retained Earnings | 77.07 M | |||
| Working Capital | 6.32 M | |||
| Current Asset | 6.57 M | |||
| Current Liabilities | 4.47 M | |||
| Annual Yield | 0.04 % | |||
| Five Year Return | 1.88 % | |||
| Net Asset | 163.92 M | |||
| Last Dividend Paid | 0.15 |
About CORTEX PHARMACEUTIC Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze CORTEX PHARMACEUTIC's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CORTEX PHARMACEUTIC using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CORTEX PHARMACEUTIC based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Consideration for investing in CORTEX Stock
If you are still planning to invest in CORTEX PHARMACEUTIC check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the CORTEX PHARMACEUTIC's history and understand the potential risks before investing.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Stocks Directory Find actively traded stocks across global markets | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |